250 related articles for article (PubMed ID: 29557723)
1. In silico identification and design of potent peptide inhibitors against PDZ-3 domain of Postsynaptic Density Protein (PSD-95).
Sharma T; Siddiqi MI
J Biomol Struct Dyn; 2019 Mar; 37(5):1241-1253. PubMed ID: 29557723
[TBL] [Abstract][Full Text] [Related]
2. An in silico analysis of the binding modes and binding affinities of small molecule modulators of PDZ-peptide interactions.
Tiwari G; Mohanty D
PLoS One; 2013; 8(8):e71340. PubMed ID: 23951139
[TBL] [Abstract][Full Text] [Related]
3. Molecular Dynamics Simulations of Wild Type and Mutants of SAPAP in Complexed with Shank3.
Piao L; Chen Z; Li Q; Liu R; Song W; Kong R; Chang S
Int J Mol Sci; 2019 Jan; 20(1):. PubMed ID: 30626119
[TBL] [Abstract][Full Text] [Related]
4. Engineering selective competitors for the discrimination of highly conserved protein-protein interaction modules.
Rimbault C; Maruthi K; Breillat C; Genuer C; Crespillo S; Puente-Muñoz V; Chamma I; Gauthereau I; Antoine S; Thibaut C; Tai FWJ; Dartigues B; Grillo-Bosch D; Claverol S; Poujol C; Choquet D; Mackereth CD; Sainlos M
Nat Commun; 2019 Oct; 10(1):4521. PubMed ID: 31586061
[TBL] [Abstract][Full Text] [Related]
5. Ligand-dependent intra- and interdomain motions in the PDZ12 tandem regulate binding interfaces in postsynaptic density protein-95.
Kovács B; Zajácz-Epresi N; Gáspári Z
FEBS Lett; 2020 Mar; 594(5):887-902. PubMed ID: 31562775
[TBL] [Abstract][Full Text] [Related]
6. Characterization of PDZ domain-peptide interactions using an integrated protocol of QM/MM, PB/SA, and CFEA analyses.
Tian F; Lv Y; Zhou P; Yang L
J Comput Aided Mol Des; 2011 Oct; 25(10):947-58. PubMed ID: 21964565
[TBL] [Abstract][Full Text] [Related]
7. Identification of Novel Fragments Binding to the PDZ1-2 Domain of PSD-95.
Zang J; Ye F; Solbak SMØ; Høj LJ; Zhang M; Bach A
ChemMedChem; 2021 Mar; 16(6):949-954. PubMed ID: 33305877
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous prediction of binding free energy and specificity for PDZ domain-peptide interactions.
Crivelli JJ; Lemmon G; Kaufmann KW; Meiler J
J Comput Aided Mol Des; 2013 Dec; 27(12):1051-65. PubMed ID: 24305904
[TBL] [Abstract][Full Text] [Related]
9. AMPA GluA2 subunit competitive inhibitors for PICK1 PDZ domain: Pharmacophore-based virtual screening, molecular docking, molecular dynamics simulation, and ADME studies.
Rathod SB; Prajapati PB; Pal R; Mansuri MF
J Biomol Struct Dyn; 2023 Jan; 41(1):336-351. PubMed ID: 34809533
[TBL] [Abstract][Full Text] [Related]
10. Functional interplay between protein domains in a supramodular structure involving the postsynaptic density protein PSD-95.
Laursen L; Karlsson E; Gianni S; Jemth P
J Biol Chem; 2020 Feb; 295(7):1992-2000. PubMed ID: 31831623
[TBL] [Abstract][Full Text] [Related]
11. Structure-based identification of CaMKIIα-interacting MUPP1 PDZ domains and rational design of peptide ligands to target such interaction in human fertilization.
Zhang YL; Han ZF; Sun YP
Amino Acids; 2016 Jun; 48(6):1509-21. PubMed ID: 26984442
[TBL] [Abstract][Full Text] [Related]
12. Discovery, structure-activity relationship studies, and crystal structure of nonpeptide inhibitors bound to the Shank3 PDZ domain.
Saupe J; Roske Y; Schillinger C; Kamdem N; Radetzki S; Diehl A; Oschkinat H; Krause G; Heinemann U; Rademann J
ChemMedChem; 2011 Aug; 6(8):1411-22. PubMed ID: 21626699
[TBL] [Abstract][Full Text] [Related]
13. Identification of potential PKC inhibitors through pharmacophore designing, 3D-QSAR and molecular dynamics simulations targeting Alzheimer's disease.
Iqbal S; Anantha Krishnan D; Gunasekaran K
J Biomol Struct Dyn; 2018 Nov; 36(15):4029-4044. PubMed ID: 29182053
[TBL] [Abstract][Full Text] [Related]
14. Ligand- and structure-based in silico studies to identify kinesin spindle protein (KSP) inhibitors as potential anticancer agents.
Balakumar C; Ramesh M; Tham CL; Khathi SP; Kozielski F; Srinivasulu C; Hampannavar GA; Sayyad N; Soliman ME; Karpoormath R
J Biomol Struct Dyn; 2018 Nov; 36(14):3687-3704. PubMed ID: 29064326
[TBL] [Abstract][Full Text] [Related]
15. Computational design of selective peptides to discriminate between similar PDZ domains in an oncogenic pathway.
Zheng F; Jewell H; Fitzpatrick J; Zhang J; Mierke DF; Grigoryan G
J Mol Biol; 2015 Jan; 427(2):491-510. PubMed ID: 25451599
[TBL] [Abstract][Full Text] [Related]
16. Conformational changes in the third PDZ domain of the neuronal postsynaptic density protein 95.
Camara-Artigas A; Murciano-Calles J; Martínez JC
Acta Crystallogr D Struct Biol; 2019 Apr; 75(Pt 4):381-391. PubMed ID: 30988255
[TBL] [Abstract][Full Text] [Related]
17. Ensemble-Based Analysis of the Dynamic Allostery in the PSD-95 PDZ3 Domain in Relation to the General Variability of PDZ Structures.
Dudola D; Hinsenkamp A; Gáspári Z
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33172212
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a small-molecule inhibitor of Dvl-CXXC5 interaction by computational approaches.
Ma S; Choi J; Jin X; Kim HY; Yun JH; Lee W; Choi KY; No KT
J Comput Aided Mol Des; 2018 May; 32(5):643-655. PubMed ID: 29627878
[TBL] [Abstract][Full Text] [Related]
19. Discovery of Novel DPP-IV Inhibitors as Potential Candidates for the Treatment of Type 2
Musoev A; Numonov S; You Z; Gao H
Molecules; 2019 Aug; 24(16):. PubMed ID: 31394858
[TBL] [Abstract][Full Text] [Related]
20. Inhalational anesthetics disrupt postsynaptic density protein-95, Drosophila disc large tumor suppressor, and zonula occludens-1 domain protein interactions critical to action of several excitatory receptor channels related to anesthesia.
Tao F; Chen Q; Sato Y; Skinner J; Tang P; Johns RA
Anesthesiology; 2015 Apr; 122(4):776-86. PubMed ID: 25654436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
